Johnson & Johnson Total Liabilities 1986-2025 | JNJ

Johnson & Johnson total liabilities from 1986 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Johnson & Johnson total liabilities for the quarter ending September 30, 2025 were $114.916B, a 4.9% increase year-over-year.
  • Johnson & Johnson total liabilities for 2024 were $108.614B, a 9.95% increase from 2023.
  • Johnson & Johnson total liabilities for 2023 were $98.784B, a 10.66% decline from 2022.
  • Johnson & Johnson total liabilities for 2022 were $110.574B, a 2.39% increase from 2021.
Johnson & Johnson Annual Total Liabilities
(Millions of US $)
2024 $108,614
2023 $98,784
2022 $110,574
2021 $107,995
2020 $111,616
2019 $98,257
2018 $93,202
2017 $97,143
2016 $70,790
2015 $62,261
2014 $60,606
2013 $58,630
2012 $56,521
2011 $56,564
2010 $46,329
2009 $44,094
2008 $42,401
2007 $37,635
2006 $31,238
2005 $20,154
2004 $21,504
2003 $21,394
2002 $17,859
2001 $14,255
2000 $13,850
1999 $12,950
1998 $12,621
1997 $9,094
1996 $9,174
1995 $8,828
1994 $8,546
1993 $6,674
1992 $6,713
1991 $4,887
1990 $4,606
1989 $3,771
1988 $3,616
1987 $3,061
1986 $3,053
1985 $1,744
Johnson & Johnson Quarterly Total Liabilities
(Millions of US $)
2025-06-30 $114,916
2025-03-31 $115,562
2024-12-31 $108,614
2024-09-30 $108,129
2024-06-30 $109,550
2024-03-31 $101,946
2023-12-31 $98,784
2023-09-30 $94,833
2023-06-30 $115,277
2023-03-31 $125,100
2022-12-31 $110,574
2022-09-30 $100,525
2022-06-30 $101,367
2022-03-31 $103,646
2021-12-31 $107,995
2021-09-30 $108,956
2021-06-30 $106,860
2021-03-31 $106,723
2020-12-31 $111,616
2020-09-30 $106,220
2020-06-30 $95,402
2020-03-31 $93,723
2019-12-31 $98,257
2019-09-30 $97,311
2019-06-30 $94,332
2019-03-31 $91,072
2018-12-31 $93,202
2018-09-30 $91,077
2018-06-30 $92,476
2018-03-31 $93,370
2017-12-31 $97,143
2017-09-30 $81,679
2017-06-30 $80,885
2017-03-31 $74,577
2016-12-31 $70,790
2016-09-30 $67,600
2016-06-30 $67,341
2016-03-31 $63,584
2015-12-31 $62,261
2015-09-30 $61,712
2015-06-30 $60,905
2015-03-31 $60,712
2014-12-31 $60,606
2014-09-30 $55,506
2014-06-30 $57,152
2014-03-31 $56,748
2013-12-31 $58,630
2013-09-30 $57,129
2013-06-30 $54,660
2013-03-31 $54,681
2012-12-31 $56,521
2012-09-30 $55,190
2012-06-30 $55,316
2012-03-31 $54,828
2011-12-31 $56,564
2011-09-30 $50,294
2011-06-30 $49,982
2011-03-31 $48,287
2010-12-31 $46,329
2010-09-30 $40,956
2010-06-30 $39,449
2010-03-31 $40,527
2009-12-31 $44,094
2009-09-30 $41,174
2009-06-30 $41,191
2009-03-31 $42,309
2008-12-31 $42,401
2008-09-30 $41,990
2008-06-30 $41,678
2008-03-31 $40,370
2007-12-31 $37,635
2007-09-30 $35,092
2007-06-30 $31,561
2007-03-31 $32,138
2006-12-31 $31,238
2006-09-30 $20,665
2006-06-30 $20,248
2006-03-31 $21,010
2005-12-31 $20,154
2005-09-30 $19,727
2005-06-30 $19,384
2005-03-31 $20,792
2004-12-31 $21,504
2004-09-30 $20,576
2004-06-30 $20,119
2004-03-31 $20,374
2003-12-31 $21,394
2003-09-30 $20,921
2003-06-30 $21,216
2003-03-31 $17,958
2002-12-31 $17,859
2002-09-30 $16,578
2002-06-30 $16,460
2002-03-31 $14,573
2001-12-31 $14,255
2001-09-30 $13,319
2001-06-30 $13,390
2001-03-31 $11,783
2000-12-31 $13,850
2000-09-30 $12,298
2000-06-30 $12,326
2000-03-31 $12,813
1999-12-31 $12,950
1999-09-30 $12,724
1999-06-30 $12,382
1999-03-31 $12,524
1998-12-31 $12,621
1998-09-30 $9,395
1998-06-30 $8,996
1998-03-31 $9,110
1997-12-31 $9,094
1997-09-30 $9,495
1997-06-30 $9,283
1997-03-31 $9,446
1996-12-31 $9,174
1996-09-30 $9,232
1996-06-30 $9,065
1996-03-31 $9,112
1995-12-31 $8,828
1995-09-30 $8,777
1995-06-30 $8,825
1995-03-31 $8,758
1994-12-31 $8,546
1994-09-30 $7,840
1994-06-30 $6,821
1994-03-31 $6,734
1993-12-31 $6,674
1993-09-30 $6,706
1993-06-30 $6,508
1993-03-31 $6,419
1992-12-31 $6,713
1992-09-30 $5,840
1992-06-30 $5,525
1992-03-31 $4,724
1991-12-31 $4,887
1991-09-30 $4,497
1991-06-30 $4,365
1991-03-31 $4,367
1990-12-31 $4,606
1990-09-30 $4,808
1990-06-30 $4,623
1990-03-31 $4,354
1989-12-31 $3,771
1989-09-30 $3,678
1989-06-30 $3,852
1989-03-31 $3,743
1988-12-31 $3,616
1988-09-30 $3,395
1988-06-30 $3,488
1988-03-31 $3,298
1987-12-31 $3,061
1987-09-30 $3,435
1987-06-30 $3,344
1987-03-31 $3,220
1986-12-31 $3,053
1985-12-31 $1,744
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $450.090B $94.943B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $495.141B 66.87
Novo Nordisk (NVO) Denmark $424.453B 49.78
Merck (MRK) United States $270.018B 37.87
AbbVie (ABBV) United States $264.086B 11.85
AstraZeneca (AZN) United Kingdom $218.471B 19.74
Novartis AG (NVS) Switzerland $218.425B 15.54
Pfizer (PFE) United States $201.199B 7.39
Sanofi (SNY) $132.955B 11.89
Innoviva (INVA) United States $0.953B 10.12